Euroz Hartley don't reference any of their sources of data. Plus they are talking about the entire hyperhidrodis treatment market whereas BOT is focused only on sweaty armpits. I don't know where Euroz got that 1.6 billion figure from ...?
They state that auxiliary hyperhidrosis impacts 3.7 million individuals in the US. They then extrapolate this to include all 10 million sufferers in the US given the potential for telemedicine etc. I just wonder who is making these wild "potential" assumptions and how they are backing it up with real data.
They are brokers - of course they will paint a rosy picture - it's their job. But they could be more credible if they back up their assumptions and quoted figures with reliable sources.
Don't get me wrong - I'd like to believe what they say and I have invested a lot in BOT.
In any case - the source I quoted for the potential market growth was several years old so it's possible it was out of date.
Euroz Hartley don't reference any of their sources of data....
-
- There are more pages in this discussion • 4,165 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
-0.010(2.63%) |
Mkt cap ! $669.7M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 38.5¢ | 36.5¢ | $2.548M | 6.766M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 96148 | 36.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 782479 | 9 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| BOT (ASX) Chart |